MeiraGTx Holdings plc (MGTX) stock
MGTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/3065% below fair value
$7.98−0.16 (-1.97%)
Close on Nov 20, 2026Market cap $766.42MP/E 11.2Yield –
MeiraGTx market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
MeiraGTx's market cap was $911.74M on Nov 11, 2026, against $667.98M a year earlier. Over the last 5 years it ranged from $250.63M to $1.30B, with a median of $418.37M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $911.74M | +42.5% |
| 2025 | Dec 31, 2025 | $639.81M | +35.2% |
| 2024 | Dec 31, 2024 | $473.17M | +13.1% |
| 2023 | Dec 29, 2023 | $418.37M | +43.5% |
| 2022 | Dec 30, 2022 | $291.51M | -72.3% |
| 2021 | Dec 31, 2021 | $1.05B | +80.9% |
| 2020 | Dec 31, 2020 | $581.56M | -20.6% |
| 2019 | Dec 31, 2019 | $732.17M | +179.4% |
| 2018 | Dec 31, 2018 | $262.06M | – |
See a number that looks wrong?